Task: Text Completion
Input (English): No. 107-204, 116 Stat. 745 (2002). 142 . See 15 U.S.C. § 7241(a)(4). 143 . See Compl. ¶¶ 75-78. 144 . Id. ¶ 78. 145 . See Caiola, 295 F.3d at 331. 146 . Compl. ¶ 78. 147 . Id. 148 . See id. 149 . See id. V 8. 150 . See id. ¶¶ 131-132. 151 . Novak, 216 F.3d at 309 (quotations omitted). 152 . See Compl. ¶¶ 133-137. 153 . See id. ¶¶ 6, 44, 48-49, 54-56, 62, 108. 154 . In re Scottish Re Group, 524 F.Supp.2d at 392 (quotations omitted). 155 . See Tellabs, 127 S.Ct. at 2511. 156 . See Compl. ¶¶ 8, 130. 157 . See Kalnit, 264 F.3d at 139 (“Motives that are generally possessed by most corporate directors and officers do not suffice; instead, plaintiffs must assert a concrete and personal benefit to the individual defendants resulting from the fraud.”). See also Chemical Bank, 726 F.2d at 939 (<HOLDING>). 158 . See Compl ¶¶ 8, 130. 159 . See In re 
 Holding statements: (A) holding that a private plaintiff is not entitled to maintain an aiding and abetting action under  10b or rule 10b  5 (B) holding that a claim arises from the purchase or sale of a security only if there is an allegation of fraud in the purchase sale or issuance of the  instrument (C) holding that section 10b violation occurs on date of alleged misrepresentation not the date of the sale or purchase of securities (D) holding that a pledge is a sale and purchase of a security under  10b (E) holding that the wording of  10b making fraud in connection with purchase or sale of security a violation of the act is surely badly strained when construed to provide a cause of action not to purchasers or sellers of securities but to the world at large
Output (English): (D)